Studies have shown that CBP interacts with the promoter of EGFR-AS1, activating H3K27ac and subsequently leading to the upregulation of EGFR-AS1, which influences the WNT pathway through ACTN4, promoting cervical cancer cell growth (153). The gene discussed is EGFR; the disease is cervical carcinoma.